United States Drug Enforcement Administration

WASHINGTON – The U.S. Drug Enforcement Administration recognizes the Red Ribbon Campaign – the nation’s largest drug prevention effort - throughout the month of October by providing drug prevention, awareness, and education that encourages living healthy and drug-free. DEA’s Red Ribbon Week is recognized October 23 through October 31 every...

WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...

WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...

WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...

WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...

WASHINGTON – The United States Drug Enforcement Administration launched its annual Red Ribbon Campaign – the nation’s largest drug prevention effort – on October 23 to unite communities across the country in the shared goal of preventing drug use and addiction. This year’s theme, “Celebrate Life. Live Drug Free,” reminds...

WASHINGTON – The United States Drug Enforcement Administration kicked off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort, on October 23. “Learning about the dangers of drugs, and talking about this with family and friends, reduces drug use, drug misuse, and addiction—especially for young people,” said DEA...

WASHINGTON – The Department of Justice announced today criminal charges against 138 defendants, including 42 doctors, nurses, and other licensed medical professionals, in 31 federal districts across the United States, for their alleged participation in various healthcare fraud schemes that resulted in approximately $1.4 billion in alleged losses. The charges...